FDAnews
www.fdanews.com/articles/176680-polymedco-launches-epi-procolon

Polymedco Launches Epi proColon

May 17, 2016

Polymedco has launched the Epi proColon, a colorectal cancer blood test for patients not able to complete a stool test or colonoscopy, the company announced Monday.

The test, approved last month, falls under a commercialization agreement between Epigenomics AG and Polymedco.

Epi proColon is the first FDA-approved DNA blood test for colorectal cancer screening, according to Polymedco. — Anisa Jibrell

 

View More Stories